Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-064076
Filing Date
2024-08-01
Accepted
2024-08-01 16:05:28
Documents
65
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0209586-10q_inmunebio.htm   iXBRL 10-Q 544267
2 FIRST AMENDMENT TO THE BYLAWS OF INMUNE BIO INC ea020958601ex3-1_inmune.htm EX-3.1 4746
3 CERTIFICATION ea020958601ex31-1_inmune.htm EX-31.1 10379
4 CERTIFICATION ea020958601ex31-2_inmune.htm EX-31.2 10476
5 CERTIFICATION ea020958601ex32-1_inmune.htm EX-32.1 4351
6 CERTIFICATION ea020958601ex32-2_inmune.htm EX-32.2 4413
  Complete submission text file 0001213900-24-064076.txt   3950465

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE inmb-20240630.xsd EX-101.SCH 43323
8 XBRL CALCULATION FILE inmb-20240630_cal.xml EX-101.CAL 31323
9 XBRL DEFINITION FILE inmb-20240630_def.xml EX-101.DEF 193906
10 XBRL LABEL FILE inmb-20240630_lab.xml EX-101.LAB 367857
11 XBRL PRESENTATION FILE inmb-20240630_pre.xml EX-101.PRE 190638
68 EXTRACTED XBRL INSTANCE DOCUMENT ea0209586-10q_inmunebio_htm.xml XML 346847
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38793 | Film No.: 241166544
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)